Electronic Clinical Outcome Assessment (eCOA) Services

healthcare-workers-sharing-a-tablet-device-data-with-a-coworker-ss-385048636-650x425

eCOA for Clinical Trials

Electronic Clinical Outcome Assessment (eCOA) systems are a technology that enables the capture of clinical trial data directly from patients, clinicians, and observers. This umbrella term covers any digital means of documenting patients’ condition, symptoms, and treatment effects. Electronic Patient-Reported Outcomes (ePRO) are a subset of eCOA, and represent the data collected directly from patients without third-party amendment or interpretation. ePROs are often conducted remotely on devices such as tablets, computers, and smartphones, whereas eCOA may also be captured in-person and encompasses clinician assessments and medical devices.

In many clinical trials, eCOAs are a critical component because they provide valuable insights into a patient’s disease progression and overall well-being. Decades ago, patient reported outcomes (PROs) were collected using paper-based methods, which were liable to loss/destruction, transcription errors, and data inconsistency. Today’s eCOA innovations allow patients to complete questionnaires electronically, either on their own devices or through a dedicated study portal. Patients can complete eCOA assessments from their own homes, and the data can be transmitted securely to the clinical trial database. 

3 Key Benefits of eCOA

service icon

Upgrade End User Experience

With more visual design tools, reference material embedding, and clearer instructions, Sponsors can leverage eCOA to improve patient engagement and adherence to...

Read More

Upgrade End User Experience

With more visual design tools, reference material embedding, and clearer instructions, Sponsors can leverage eCOA to improve patient engagement and adherence to treatments. Additionally, by providing the flexibility of data completion from anywhere, decentralized clinical trials are made possible.

Read Less
email-icon

Analyze Data in Real-Time

Compared to traditional methods, digital assessments play a larger role in decentralized and hybrid trials. Data quality and streamlined collection become especially...

Read More

Analyze Data in Real-Time

Compared to traditional methods, digital assessments play a larger role in decentralized and hybrid trials. Data quality and streamlined collection become especially paramount, as clinicians do not fully control the study environment. Real-time data capture is particularly helpful in this context as it enables immediate monitoring and tracking of success criteria; furthermore, site staff can identify safety issues and trends earlier.

Read Less
RDTechnology

Comply with Regulations and Quality Standards

With audit trails, patient-specific credentials, and secured storage, electronic data capture ensures compliance with regulations such as FDA 21 CFR Part...

Read More

Comply with Regulations and Quality Standards

With audit trails, patient-specific credentials, and secured storage, electronic data capture ensures compliance with regulations such as FDA 21 CFR Part 11. Furthermore, logic checks and rules can be built into forms to standardize data upon entry, minimizing the number of quality checks and verification needed throughout a study.

Read Less

Key Considerations for eCOA Implementation

Build Time

Standard eCOA development requires a series of steps, including licensing, build, image approval, UAT, IRB/EC submissions, and deployment. This process may take 3-4 months depending on the complexity of your study and the translations required.

Vendor Expertise

Choose an experienced vendor who understands your study’s unique requirements, supports all required languages, and provides expert guidance. ProPharma specializes in vendor assessment, guiding your organization through RFX and system demos to select a fit-for-purpose system.

Stakeholder Involvement

Identify relevant stakeholders and capture the patients’ and caregivers’ voice early during the implementation to ensure your eCOA solution fosters patient engagement and reduces sites’ administrative burden.

Interoperability

To reduce duplicative data entry, Sponsors may require data transfer to EDC and information flow to RTSM. Assess whether your eCOA vendor offers published APIs or direct integrations.

5 Important Factors in Selecting an eCOA 

Before contacting vendors, it’s important to collect the following information about your organization: 
partner icon

Business Requirements

Business Requirements

regulatory-operations

Budget

Budget

calendar-icon-1-1

Timeline

Timeline

RDSolutionsConsulting

Complexity

Complexity

Submissions

Compliance

Compliance

Business Requirements

eCOA implementations are not one-size-fits-all. Determine which features are nice-to-have, and which ones are critical for your organization. For example, if a library of approved and reusable forms is a requirement, confirm that potential vendors will support those needs.

Business professionals smiling at a desk reviewing data

Budget

eCOA systems should be viewed as an investment. Licensing, system support, and subscription fees may be continuing costs that should be compared against your department’s budget. Consider how pricing may change as you build more studies and add system users. 

Two lab workers looking at material in a petridish

Timeline

Consider each vendor’s proposed implementation timeline against the time constraints of your company. If your study’s inclusion criteria include patient studies and enrollment is starting in eight weeks, narrow consideration down to vendors who can complete the project by that timeframe. 

Two engineers reviewing a device in front of computer monitors

Complexity

Purchasing an eCOA is an investment not only of money, but also of time and effort. How much training will your staff need to learn the system properly, and do you have resources in-house to build a dedicated support team? Additionally, factor in your team’s adaptability and buy-in when selecting a particular solution. 

Hand holding tablet device

Compliance

Does the eCOA software meet all standards imposed by IRBs, HIPAA, GDPR, ALCOA, and 21 CFR Part 11? Assess the vendor’s agility in releasing new features to support evolving regulations. 

Business professionals collaborating in an office around a laptop

ProPharma: Your Organization’s Preferred Partner for eCOA Selection & Implementation

ProPharma’s R&D Technology team understands the criticality of selecting the right electronic clinical outcome assessment and excels in aligning your companies’ needs with regulations and system best practices. Our comprehensive approach and expert knowledge ensure that your organization is set up for long-term success.   Our team also has extensive experience in these additional areas: 

Service Category

How We Can Help

Strategy & Business Process Optimization

  • eCOA
  • Roadmap Development

Clinical Research Solutions

  • Staff Augmentation

Implementation Support

  • Project Management
  • Configuration & API Integrations (EDC, CTMS)
  • Controlled Document Creation (SOPs and Job Aids)
  • User Administration & Training
  • Change Management

Validation

  • eCOA Validation Coordination
  • User Acceptance Test Scripts

Managed Services

  • System Administration
  • Release Management
  • System Optimization

Expert eCOA Implementation & Management

If you are interested in implementing or optimizing your eCOA, ProPharma's R&D Technology team comprises experienced consultants who can advise your digital transformation. If you are interested in partnering with ProPharma on any of the services above, contact us via the form below. We look forward to working with you!

News & Insights

Excelling in the JAPAC Medical Information Landscape: Key Considerations and Insights

July 24, 2024

Excelling in the JAPAC Medical Information Landscape: Key Considerations and Insights

Discover strategies for establishing a medical information function in JAPAC, overcoming diverse regulations, data privacy laws, and cultural nuances.

Safety Data Exchange Agreements (SDEAs) and Pharmacovigilance Agreements (PVAs) – An Overview

July 22, 2024

Safety Data Exchange Agreements (SDEAs) and Pharmacovigilance Agreements (PVAs) – An Overview

An overview of Safety Data Exchange Agreements (SDEAs) and Pharmacovigilance Agreements (PVAs), highlighting their importance in ensuring compliance with regulatory requirements and patient safety in...

Meet the Expert: Dana E. Vanderwall, PhD.

July 18, 2024

Meet the Expert: Dana E. Vanderwall, PhD.

Meet the Expert: Dana E. Vanderwall, PhD., a Senior Director Digital Transformation at ProPharma, shares insights on PSMF and robust quality management systems.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

May 2, 2024

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

ProPharma and PBL introduce Cell Factory Box for decentralized Cell & Gene Therapies manufacturing, reducing costs and improving patient access to life-saving treatments.

ProPharma Now Certified as Medidata Rave EDC Accredited Partner

April 18, 2024

ProPharma Now Certified as Medidata Rave EDC Accredited Partner

ProPharma receives Medidata Rave EDC accreditation, enhancing clinical trial efficiency. Learn about the latest milestone delivering cutting-edge solutions.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

November 27, 2023

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

Ernst & Young announces Michael Stomberg as a finalized for Entrepreneur Of The Year® 2023 National Award to celebrate ambitious entrepreneurs.

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

October 11, 2023

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

Everest Group has recognized ProPharma Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023.

Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

News & Insights

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

May 2, 2024

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

ProPharma and PBL introduce Cell Factory Box for decentralized Cell & Gene Therapies manufacturing, reducing costs and improving patient access to life-saving treatments.

ProPharma Now Certified as Medidata Rave EDC Accredited Partner

April 18, 2024

ProPharma Now Certified as Medidata Rave EDC Accredited Partner

ProPharma receives Medidata Rave EDC accreditation, enhancing clinical trial efficiency. Learn about the latest milestone delivering cutting-edge solutions.

Previous Post Arrow Next Post Arrow
ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

November 27, 2023

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

Ernst & Young announces Michael Stomberg as a finalized for Entrepreneur Of The Year® 2023 National Award to celebrate ambitious entrepreneurs.

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

October 11, 2023

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

Everest Group has recognized ProPharma Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023.

Previous Award Arrow Next Award Arrow
Excelling in the JAPAC Medical Information Landscape: Key Considerations and Insights

July 24, 2024

Excelling in the JAPAC Medical Information Landscape: Key Considerations and Insights

Discover strategies for establishing a medical information function in JAPAC, overcoming diverse regulations, data privacy laws, and cultural nuances.

Safety Data Exchange Agreements (SDEAs) and Pharmacovigilance Agreements (PVAs) – An Overview

July 22, 2024

Safety Data Exchange Agreements (SDEAs) and Pharmacovigilance Agreements (PVAs) – An Overview

An overview of Safety Data Exchange Agreements (SDEAs) and Pharmacovigilance Agreements (PVAs), highlighting their importance in ensuring compliance with regulatory requirements and patient safety in...

Meet the Expert: Dana E. Vanderwall, PhD.

July 18, 2024

Meet the Expert: Dana E. Vanderwall, PhD.

Meet the Expert: Dana E. Vanderwall, PhD., a Senior Director Digital Transformation at ProPharma, shares insights on PSMF and robust quality management systems.

Previous Post Arrow Next Post Arrow
Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

Previous Resource Arrow Next Resource Arrow